FDA Inspection 1224398 — Suma R. Satti, M.D.
The FDA completed an inspection of Suma R. Satti, M.D. on Nov 17, 2023 in Covington, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 17, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Covington, LA (United States)
Additional Details
Clinical Investigator (CI)